Medical device briefs
Thursday, 05 February, 2009
Nanosonics has been granted approval by the Therapeutic Goods Administration to market its Trophon EPR device.
The device disinfects ultrasound probes and is aimed at hospitals, specialists and radiology clinics.
It has received earlier approval in the EU, Canada and New Zealand and is awaiting approval from the US FDA.
Polartechnics has signed agreements in Thailand, the Philippines, Indonesia and Sri Lanka for its TruScreen and CerviScreen diagnostics.
TruScreen is a point-of-care test for HPV while CerviScreen is a self-administered test.
Listed lab consumables company Fluorotechnics has changed its trading name to Gel Company. Its ASX name will remain the same.
Could this 'nanobone' material allow children to regrow bone?
Australian scientists believe they have found an alternative to invasive bone graft procedures in...
The last mile of life sciences innovation
How do we translate technological possibility into meaningful real-world impact?
Machine learning uncovers patterns in DNA methylation
A new machine-learning method identifies differentially methylated DNA regions without sample...
